Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inositol and Metformin in Mediterranean vs Low-Carbohydrate Diets for PCOS
NCT07770711Recruiting
- Sponsor
- Dicle University
- Start
- Aug 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of liquid metformin (Aspargo Labs) and bCalm in polycystic ovary syndrome (PCOS), insulin resistance (IR) and obesity (6 arms), sponsored by Dicle University. Primary endpoint: Homeostatic Model Assessment for Insulin Resistance at 2 months. Started Aug 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)bCalm
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)obesity
Beyond the preview
Go deeper on NCT07770711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07770711.